This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Contraindications and precautions

Authoring team

Contraindications include:

  • history of deep vein thrombosis or thromboembolism, endometrial or breast cancer, unexplained uterine bleeding
  • liver insufficiency including cholestasis
  • severe renal impairment

The SPC for raloxifene advises that cholestyramine should not be given with raloxifene - cholestyramine reduces the absorption and enterohepatic circulation of raloxifene.

Raloxifene may cause a modest increase in prothrombin time in patients receiving warfarin or other coumarins - this should be checked for.

The summary of product characteristics must be checked before prescribing this drug.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.